Abstract
Isotype-switch variants can easily be detected in a significant proportion of multiple myeloma (MM) patients. The biological significance of these isotype-switch variants remains obscure. Therefore, we studied the appearance of these isotype-switch variants in two murine MM models, 5T2MM and 5T33MM, both of IgG isotype. With a MM-specific PCR assay we could detect isotype-switch variants in the bone marrow of both the 5T2MM and the 5T33MM bearing mice, reflecting again the close resemblance of this mouse model to the human MM. These isotype-switch variants were not found in an in vitro stroma-independent variant of the 5T33MM line. However, when this 5T33MMvitro line was injected into young syngeneic mice, isotype-switch variants appeared thereafter in the isolated tumour cells. These isotype-switch variants could only originate from the MM-IgG expressing cell since IgG subclones from the 5T33MMvitro line again gave rise to isotype-switch variants. The appearance of IgA cells can be explained by down-stream switching of IgG to IgA, while the emergence of IgM cells have to occur via trans-switching to the sister chromatid as the Cμ region is deleted from the CIS-chromosome. This study demonstrates that isotype-switch variants originate from the major tumour clone suggesting no role for the MM-IgM expressing cell as a pre-switch precursor MM cell. The appearance of isotype-switch variants should be considered as a rare but normal event now becoming visible due to the high number of clonal cells present in MM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thielemans K . Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation Blood 1992 80: 2326–2335
Vescio RA, Cao J, Hong CH, Lee JC, Wu CH, Der Danielian M, Wu V, Newman R, Lichtenstein AK, Berenson J . Myeloma Ig heavy chain V region sequences reveal prior antigeneic selection and marked somatic mutation but no intraclonal diversity J Immunol 1995 155: 2487–2497
Ralph QM, Brisco MJ, Joshua DE, Brown R, Gibson J, Morley AA . Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone – evidence from the Ig heavy chain gene Blood 1993 82: 202–206
Van Riet I, Heirman C, Lacor P, De Waele M, Thielemans K, Van Camp B . Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies Br J Haematol 1989 73: 289–295
Jensen GS, Mant MJ, Belch AJ, Berenson JR, Ruether BA, Pilarski LM . Selective expression of CD45 isoforms defines CALLA+ monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells Blood 1991 78: 711–719
Berenson J, Wong R, Kim K, Brown N, Lichtenstein A . Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma Blood 1987 70: 1550–1553
Billadeau D, Van-Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE . Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma Blood 1996 88: 289–296
Bakkus MHC, Van Riet I, Van Camp B, Thielemans K . Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell Br J Haematol 1994 87: 68–74
Billadeau D, Ahmann G, Greipp P, Van Ness B . The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell J Exp Med 1993 178: 1023–1031
Corradini P, Boccadoro M, Voena C, Pileri A . Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in IgG and IgA secreting multiple myelomas J Exp Med 1993 178: 1091–1096
Bakkus MHC, Van Riet U, De Greef C, Van Camp B, Thielemans K . The clonogenic precursor cell in multiple myeloma Leuk Lymphoma 1995 18: 221–229
Bakkus MHC, Gomez La Fuente PB, Van de Velde H, Van Riet I, Thielemans K, Van Camp B . Isolation and expansion of multiple myeloma related cells in the ‘CD40L’ system Blood 1995 86 (Suppl.): 58a
Radl J, Croese JW, Zurcher C, v . d. Enden-Vieveen MHM, de Leeuw AM. Animal model of human disease: multiple myeloma Am J Pathol 1988 132: 177–181
Radl J, De Glopper E, Schuit HR, Zurcher C . Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice J Immunol 1979 122: 609–613
Asosingh K, Radl J, Van Riet I, Van Camp B, Vanderkerken K . The 5TMM series: a useful in vivo mouse model of human multiple myeloma. A mini-review Hematology J 2000 1: 351–356
Vanderkerken K, De Raeve H, Goes E, Van Meirvenne S, Radl J, Van Riet I, Thielemans K, Van Camp B . Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse Br J Cancer 1997 76: 451–460
Vanderkerken K, Asosingh K, Braet F, Van Riet I, Van Camp B . Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells Blood 1999 93: 235–241
Asosingh K, Gunthert U, Bakkus MH, De Raeve H, Goes E, Van Riet I, Van Camp B, Vanderkerken K . In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells Cancer Res 2000 60: 3096–3104
Zhu D, van Arkel C, King CA, van Meirvenne S, de Greef C, Thielemans K, Radl J, Stevenson FK . Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumors with clinical features of human disease Immunology 1998 93: 162–170
Vanderkerken K, De Greef C, Asosingh K, Arteta B, De Veerman M, Vande Broek I, Van Riet I, Kobayashi M, Smedsrod B, Van Camp B . Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse Br J Cancer 2000 82: 953–959
Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, Van den Berghe H . Successful use of the same slide for consecutive fluorescence in situ hybridization experiments Genes Chromosomes Cancer 1996 16: 261–264
Meyerhans A, Vartanian JP, Wain-Hobson S . DNA recombination during PCR Nucleic Acids Res 1990 18: 1687–1691
Spira G, Gregor P, Aguila HL, Scharff MD . Clonal variants of hybridoma cells that switch isotype at a high frequency Proc Natl Acad Sci USA 1994 91: 3423–3427
Esser C, Radbruch A . Immunoglobulin class switching: molecular and cellular analysis Annu Rev Immunol 1990 8: 717–735
Kabat EA, Wu TT, Reid-Miller M, Perry HM, Gottesman KS . Sequences of Proteins of Immunological Interest US Department of Health and Human Services: Washington, DC 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bakkus, M., Asosingh, K., Vanderkerken, K. et al. Myeloma isotype-switch variants in the murine 5T myeloma model: evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour. Leukemia 15, 1127–1132 (2001). https://doi.org/10.1038/sj.leu.2402164
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402164